These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8198414)

  • 1. The EC randomised controlled trial of prophylactic ethamsylate for very preterm neonates: early mortality and morbidity. The EC Ethamsylate Trial Group.
    Arch Dis Child Fetal Neonatal Ed; 1994 May; 70(3):F201-5. PubMed ID: 8198414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infants.
    Hunt R; Hey E
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004343. PubMed ID: 20091562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethamsylate in the prevention of periventricular-intraventricular hemorrhage in premature infants.
    Chen JY
    J Formos Med Assoc; 1993 Oct; 92(10):889-93. PubMed ID: 7908570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic ethamsylate for periventricular haemorrhage.
    Cooke RW; Morgan ME
    Arch Dis Child; 1984 Jan; 59(1):82-3. PubMed ID: 6696506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants.
    Benson JW; Drayton MR; Hayward C; Murphy JF; Osborne JP; Rennie JM; Schulte JF; Speidel BD; Cooke RW
    Lancet; 1986 Dec; 2(8519):1297-300. PubMed ID: 2878174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ethamsylate in preventing periventricular-intraventricular hemorrhage in premature infants below 34 weeks of gestation.
    Sanghvi KP; Merchant RH; Karnik A; Kulkarni A
    Indian Pediatr; 1999 Jul; 36(7):653-8. PubMed ID: 10740301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ethamsylate on neonatal mortality in preterm infants.
    Erdem G; Yurdakök M; Tekinalp G; Hiçsönmez G
    Turk J Pediatr; 1988; 30(2):93-7. PubMed ID: 3242186
    [No Abstract]   [Full Text] [Related]  

  • 8. Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial.
    Schulte J; Osborne J; Benson JW; Cooke R; Drayton M; Murphy J; Rennie J; Speidel B
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F31-5. PubMed ID: 15613570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial of prophylactic etamsylate: follow up at 2 years of age.
    Elbourne D; Ayers S; Dellagrammaticas H; Johnson A; Leloup M; Lenoir-Piat S;
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F183-7. PubMed ID: 11320045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etamsylate for prevention of periventricular haemorrhage.
    Hunt RW
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F3-5. PubMed ID: 15613569
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: outcome at 2 years. Northern Neonatal Nursing Initiative Trial Group.
    Lancet; 1996 Jul; 348(9022):229-32. PubMed ID: 8684200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular hemorrhage in preterm infants: coagulation perspectives.
    Kuperman AA; Kenet G; Papadakis E; Brenner B
    Semin Thromb Hemost; 2011 Oct; 37(7):730-6. PubMed ID: 22187395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethamsylate in the prevention of patent ductus arteriosus.
    Rosti L; Piva D; Rosti D
    Arch Pediatr Adolesc Med; 1994 Oct; 148(10):1103-4. PubMed ID: 7921106
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants.
    Bruschettini M; Romantsik O; Zappettini S; Banzi R; Ramenghi LA; Calevo MG
    Cochrane Database Syst Rev; 2016 Mar; 3():CD011636. PubMed ID: 26998583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intra-partum ethamsylate (dicynone) administration in the prevention of cerebral hemorrhage in premature infants].
    Györe F; Keserü T; Gyuranecz M; Bognár I; Kerekes L; Simon G
    Orv Hetil; 1990 Dec; 131(50):2747-52. PubMed ID: 2267123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethamsylate reduces immunoreactive prostacyclin metabolite in low birthweight infants with respiratory distress syndrome.
    Rennie JM; Doyle J; Cooke RW
    Early Hum Dev; 1986 Dec; 14(3-4):239-44. PubMed ID: 3542493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic ethamsylate for periventricular haemorrhage.
    Dubowitz LM; Whitelaw A
    Arch Dis Child; 1984 May; 59(5):489-90. PubMed ID: 6732284
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis.
    Fowlie PW; Davis PG
    Arch Dis Child Fetal Neonatal Ed; 2003 Nov; 88(6):F464-6. PubMed ID: 14602691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of symptomatic patent ductus arteriosus with ethamsylate in babies treated with exogenous surfactant.
    Amato M; Hüppi P; Markus D
    J Perinatol; 1993; 13(1):2-7. PubMed ID: 8445442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic interventions to prevent intracerebral hemorrhage in preterm infants.
    Kauffman RE
    J Pediatr; 1986 Feb; 108(2):323-5. PubMed ID: 3511210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.